12. Grimm E., Mazumder A., Zhang H., and Rosenberg S., The lymphokine-activated killer cell 
phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated 
autologous human peripheral blood lymphocytes. J. Exp. Med. 155:1823-1831, 1982. 
13. Maraskovsky E., Chen W-F., and Shortman K., IL-2 and IFN-gamma are two necessary 
lymphokines in the development of cytolytic T cells. J. Immunol. 143: 1210-1214, 1989. 
14. Moller G., T cell stimulating factors. Immunol. Rev. 51, 1980. 
15. Ralph P., Nakoinz I., and Rennick D., Role of interleukin 2, interleukin 4, and alpha, beta, 
and gamma interferon in stimulating macrophage antibody-dependent tumoricidal activity. J. 
Exp. Med. 167:712-717, 1988. 
1 6. Khavari P., Cytotoxic cellular mediators of the immune response to neoplasia: a review. Yale 
J. Biol. Med. 60:409-419, 1987. 
17. Sugita K., Miyazaki J-I., Appella E., and Ozato K., Interferons increase transcription of a 
major histocompatibility class I gene via a 5' interferon consensus sequence. Mol. Cell Biol. 
7:2625-2630, 1987. 
18. Wallach, D., Fellous, M., and Revel, M., Preferential effect of y interferon on the synthesis 
of HLA antigens and their mRNAs in human cells. Nature (Lond.) 299:833-836, 1982. 
1 9. Berd D., Maguire H., Mccue P., and Mastrangelo M., Treatment of metastatic melanoma with 
an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients. Journal of 
Clinical Oncology 8:1858-1867, 1990. 
20. Bystryn, J.,-C. Tumor vaccines. Can. Metas. Rev. 9:81-91, 1990. 
21 . Hoover H., Surdyke M., Dangel R., Peters L., and Hanna M., Prospectively randomized trial 
of adjuvant active-specific immunotherapy for human colorectal cancer. Cancer 55:1236- 
1243, 1985. 
22. Stevenson F., Tumor vaccines. The FASEB Journal 5:2250-2256, 1991. 
23. Seigler, H.F., Cox, E., Mutzner, F., Shepherd, L., Nicholson, E., and Shingleton, W.W. 
Specific active immunotherapy for melanoma. Ann. Surg. 190:366-372, 1979. 
24. Fearon E., Pardoll D., Itaya T., Golumbek P., Levitsky H., Simons J., Karasuyama H., 
Vogelstein B., and Frost P., Interleukin-2 production by tumor cells bypasses T helper 
function in the generation of an antitumor response. Cell, 60:397-403, 1990. 
25. Gansbacher B., Zier K., Daniels B., Cronin K., Bannerji R., and Gilboa E., Interleukin 2 
gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. 
Exp. Med. 172:1217-1224, 1990. 
26. Golumbek P., Lazenby A., Levitsky H., Jaffee L., Karasuyama H., Baker M., Pardoll D., 
Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. 
Science 254:713-716, 1991. 
[634] 
Recombinant DNA Research, Volume 17 
